← Back to Clinical Trials
Recruiting NCT04721652

NCT04721652 Fluid Intake After Hemodialysis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04721652
Status Recruiting
Phase
Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition Chronic Kidney Disease Requiring Chronic Dialysis
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2021-02-25
Primary Completion 2025-09-30

Trial Parameters

Condition Chronic Kidney Disease Requiring Chronic Dialysis
Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Study Type OBSERVATIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-02-25
Completion 2025-09-30

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Interdialytic weight gain determines how much fluid (ultrafiltration) has to be removed during each hemodialysis session. High ultrafiltration volumes stress the organism and lead to a higher risk of death. Thirst is the main driving factor of interdialytic weight gain, and thirst is mainly driven by salt intake, molecules that increase blood tonicity (such as sugar in diabetics) and fluid loss (such as in dehydration and blood loss). It has been speculated that fluid loss during hemodialysis could increase the sense of thirst immediately following dialysis, but this statement requires further evidence.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years * Thrice weekly maintenance hemodialysis * Willing and able to provide written informed consent Exclusion Criteria: * Diabetes Mellitus * Residual Urinary Volume \> 500 ml/day * Being able to self-monitor one's body weight and blood pressure

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology